Adaptive Biotech COO Mark Adams terminated; duties absorbed by President Rubinstein

Adaptive Biotechnologies Corp

Mark Adams, COO, was informed on April 7, 2023, that his service will be terminated by May 2023.
President Julie Rubinstein will assume the Chief Operating Officer's duties.
No replacement COO has been named; organizational impact remains unclear.
Chad Robins continues as CEO; leadership transition underway.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Adams

Chief Operating Officer

ADPT · Adaptive Biotechnologies Corp

Filed: April 11, 2023, 7:59 PM ET

On April 7, 2023, Mark Adams, Chief Operating Officer of Adaptive Biotechnologies Corporation (the “Company”), was informed that his service is being terminated by May 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Adams was terminated as Chief Operating Officer at Adaptive Biotechnologies Corp.

Action: terminated
Role: Chief Operating Officer

Exact text from the filing

On April 7, 2023, Mark Adams, Chief Operating Officer of Adaptive Biotechnologies Corporation (the “Company”), was informed that his service is being terminated by May 2023.

View on SEC.gov

Adaptive Biotechnologies Corp filing history →

Source: SEC EDGAR

accession 0001193125-23-097389

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.